A Double-Blind Multi-Dose Tolerability and Pharmacokinetic Study of Teduglutide

NCT00820885 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

95

Enrollment

INDUSTRY

Sponsor class

Conditions

Pharmacokinetics and Safety of Elevated Doses

Interventions

DRUG: teduglutide
DRUG: teduglutide
DRUG: tedguglutide

Sponsor

Shire